CN105497318A - Biological agent used for enhancing immunity of organism and preparation method thereof - Google Patents
Biological agent used for enhancing immunity of organism and preparation method thereof Download PDFInfo
- Publication number
- CN105497318A CN105497318A CN201511005999.XA CN201511005999A CN105497318A CN 105497318 A CN105497318 A CN 105497318A CN 201511005999 A CN201511005999 A CN 201511005999A CN 105497318 A CN105497318 A CN 105497318A
- Authority
- CN
- China
- Prior art keywords
- preparation
- weight proportion
- culture medium
- concentrated
- strain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 54
- 230000036039 immunity Effects 0.000 title claims abstract description 27
- 230000002708 enhancing effect Effects 0.000 title claims abstract description 20
- 239000003124 biologic agent Substances 0.000 title abstract 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 37
- 238000000855 fermentation Methods 0.000 claims abstract description 24
- 230000004151 fermentation Effects 0.000 claims abstract description 24
- 239000001963 growth medium Substances 0.000 claims abstract description 24
- 240000006024 Lactobacillus plantarum Species 0.000 claims abstract description 19
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims abstract description 19
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 19
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims abstract description 19
- 229940072205 lactobacillus plantarum Drugs 0.000 claims abstract description 19
- 241000894006 Bacteria Species 0.000 claims abstract description 17
- 241000186000 Bifidobacterium Species 0.000 claims abstract description 11
- 235000003935 Hippophae Nutrition 0.000 claims abstract description 11
- 241000229143 Hippophae Species 0.000 claims abstract description 11
- 239000002609 medium Substances 0.000 claims description 23
- 239000002131 composite material Substances 0.000 claims description 18
- 229940081969 saccharomyces cerevisiae Drugs 0.000 claims description 18
- 239000007788 liquid Substances 0.000 claims description 17
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 claims description 16
- 239000004386 Erythritol Substances 0.000 claims description 16
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 claims description 16
- 229940009714 erythritol Drugs 0.000 claims description 16
- 235000019414 erythritol Nutrition 0.000 claims description 16
- 239000003223 protective agent Substances 0.000 claims description 16
- 238000000034 method Methods 0.000 claims description 15
- 150000001875 compounds Chemical class 0.000 claims description 13
- 238000012545 processing Methods 0.000 claims description 13
- 238000003756 stirring Methods 0.000 claims description 12
- 239000007787 solid Substances 0.000 claims description 11
- 235000009392 Vitis Nutrition 0.000 claims description 10
- 241000219095 Vitis Species 0.000 claims description 10
- 239000012530 fluid Substances 0.000 claims description 10
- 238000009472 formulation Methods 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 10
- 210000000582 semen Anatomy 0.000 claims description 10
- 241000186016 Bifidobacterium bifidum Species 0.000 claims description 8
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 8
- 239000008101 lactose Substances 0.000 claims description 8
- 239000007921 spray Substances 0.000 claims description 8
- 229960005486 vaccine Drugs 0.000 claims description 8
- 238000005406 washing Methods 0.000 claims description 8
- 238000000465 moulding Methods 0.000 claims description 6
- 230000001954 sterilising effect Effects 0.000 claims description 6
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 4
- 238000007599 discharging Methods 0.000 claims description 4
- 238000005507 spraying Methods 0.000 claims description 4
- 239000008187 granular material Substances 0.000 claims description 3
- 238000011534 incubation Methods 0.000 claims description 3
- 239000012669 liquid formulation Substances 0.000 claims description 3
- 230000010355 oscillation Effects 0.000 claims description 3
- 238000005516 engineering process Methods 0.000 abstract description 5
- 241000196324 Embryophyta Species 0.000 abstract description 4
- 230000000694 effects Effects 0.000 abstract description 3
- 244000005700 microbiome Species 0.000 abstract description 3
- 230000009286 beneficial effect Effects 0.000 abstract description 2
- 230000003647 oxidation Effects 0.000 abstract description 2
- 238000007254 oxidation reaction Methods 0.000 abstract description 2
- 230000002000 scavenging effect Effects 0.000 abstract description 2
- 235000009754 Vitis X bourquina Nutrition 0.000 abstract 1
- 235000012333 Vitis X labruscana Nutrition 0.000 abstract 1
- 240000006365 Vitis vinifera Species 0.000 abstract 1
- 235000014787 Vitis vinifera Nutrition 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 18
- 239000003963 antioxidant agent Substances 0.000 description 10
- 230000003078 antioxidant effect Effects 0.000 description 10
- 235000006708 antioxidants Nutrition 0.000 description 10
- 210000000952 spleen Anatomy 0.000 description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- 241000699666 Mus <mouse, genus> Species 0.000 description 6
- 238000003304 gavage Methods 0.000 description 6
- 230000036541 health Effects 0.000 description 6
- 210000000987 immune system Anatomy 0.000 description 6
- 230000000813 microbial effect Effects 0.000 description 5
- 150000003254 radicals Chemical class 0.000 description 5
- 210000001541 thymus gland Anatomy 0.000 description 5
- 238000002965 ELISA Methods 0.000 description 4
- 108060003951 Immunoglobulin Proteins 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 102000018358 immunoglobulin Human genes 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 102000004127 Cytokines Human genes 0.000 description 3
- 108090000695 Cytokines Proteins 0.000 description 3
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 3
- 102000000588 Interleukin-2 Human genes 0.000 description 3
- 108010002350 Interleukin-2 Proteins 0.000 description 3
- 102000004889 Interleukin-6 Human genes 0.000 description 3
- 108090001005 Interleukin-6 Proteins 0.000 description 3
- 229930003268 Vitamin C Natural products 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 229940027941 immunoglobulin g Drugs 0.000 description 3
- 229940100601 interleukin-6 Drugs 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 239000007800 oxidant agent Substances 0.000 description 3
- 230000001590 oxidative effect Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 230000009466 transformation Effects 0.000 description 3
- 235000019154 vitamin C Nutrition 0.000 description 3
- 239000011718 vitamin C Substances 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 238000009629 microbiological culture Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 208000019901 Anxiety disease Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 206010024264 Lethargy Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 230000003044 adaptive effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 235000014590 basal diet Nutrition 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000019504 cigarettes Nutrition 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 238000002485 combustion reaction Methods 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000008260 defense mechanism Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000000881 depressing effect Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000556 factor analysis Methods 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 1
- 235000003969 glutathione Nutrition 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 230000000004 hemodynamic effect Effects 0.000 description 1
- 208000033065 inborn errors of immunity Diseases 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 235000021179 potluck Nutrition 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 208000028529 primary immunodeficiency disease Diseases 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 208000019116 sleep disease Diseases 0.000 description 1
- 208000020685 sleep-wake disease Diseases 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 210000000955 splenic vein Anatomy 0.000 description 1
- 210000004988 splenocyte Anatomy 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- -1 tetramethyl azo azoles salt Chemical class 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7016—Disaccharides, e.g. lactose, lactulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/064—Saccharomycetales, e.g. baker's yeast
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
Abstract
The invention provides a preparation method of a biological agent used for enhancing the immunity of the organism. The preparation method includes the steps that saccharomyces cerevisiae, lactobacillus plantarum and bifidobacterium are mixed to obtain mixed bacteria, and the mixed bacteria are cultured in a brown sugar water culture medium in an airtight mode till the pH is smaller than 3.60 and then continue to be cultured for 12-15 days to obtain complex bacteria; radix puerariae, fructus hippophae, grape seeds, brown sugar and water are mixed to obtain a complex culture medium; the complex bacteria are added into the complex culture medium to be cultured for 20-25 days in an airtight mode to obtain a complex fermentation product; the complex fermentation product is further processed to the obtain the biological agent. According to the preparation method, as the active ingredients of plants are converted through the microorganism complex fermentation technology, the obtained biological agent has the advantages of being easier to absorb and utilize, significant in effect and the like, and besides, the biological agent can effectively achieve the beneficial effects of resisting oxidation, scavenging free radicals and enhancing the immunity and is a natural biological agent capable of enhancing the immunity of the organism.
Description
Technical field
The present invention relates to field of health care food, be specifically related to a kind of biological preparation, particularly relate to a kind of biological preparation for enhancing human body immunity power and preparation method thereof.
Background technology
Immunity is the defense mechanism of human body self, there is any foreign body (virus, antibacterial etc.) identifying and eliminate exotic invasive, the own cells of process aging, damage, death, degeneration, and identify and the ability of mutant cell and virus infected cell in handling body, be the physiological reaction of a kind of human bioequivalence and eliminating " dissident ".At present, the impact that the immune system producing immunity can be subject in various degree due to the factor of each fermentation, and then affect the immunity level of body, such as: the harmful substance in our ambient contamination can make human body produce the free radical of cell of impairing one's health, and these free radicals can destroy our immune system thus cause harm in various degree to human body self; Vitamin B complexes a large amount of in the bad habit such as smoking, excessive consumption of alcohol meeting consumer, vitamin C (1 cigarette combustion produces 30,000 hundred million free radicals, consumes 25mg vitamin C), thus make the immunity degradation of health; Live irregular, sufficient sleep can not be ensured, the immune system of health also can be made to come to harm; In addition, the physical training of immoderation, as excessive movement the free radical that produces also can have lethal effect to human body; Pressure, spirit depressing, chronic anxiety can weaken the ability of immune system fight disease equally; And to injure maximum factor to immune system be that nutrition is unbalanced.
When natural immune system come to harm make hypoimmunity time, the most directly performance be exactly liable to illness.And the often ill consumption that can increase the weight of body, thus be attended by have a delicate constitution, the reduction of malnutrition, lethargy, fatigue and weak, appetite, the performance such as sleep disorder, therefore, sick, have an injection, take medicine the normal potluck that just gets married.Moreover, the at every turn sick time also can be especially very long, even if temporarily get well also can recurrent exerbation again for body, if things go on like this, easily brings out major disease.
Modern medicine study achievement shows, the materials such as the polysaccharide contained in a lot of Chinese herbal medicine, organic acid, alkaloids, glycoside and volatile oil, can across-the-board regulation and give full play to the immunologic function and adaptive faculty that animal body has, therefore, there is the effect of preventing and curing diseases.Wherein, CN101904500A discloses functional food of a kind of enhancing immunity and preparation method thereof, CN102783645A discloses a kind of health product for improving immunity, CN102551067A discloses a kind of oral liquid prescription of immunity moderation power, in these prior aries, all developed by multiple Chinese herbal medicine or its extract, and need through to concoct or after processing, further effective component extracting, there is remarkable result the side of taking, but often this process very complicated; And if directly take without processing, then the obstacle owing to absorbing, cause effective ingredient not easily to utilize, the defect of DeGrain.
Summary of the invention
Based on above-mentioned background technology, the invention provides a kind of biological preparation for enhancing human body immunity power and preparation method thereof, transformed by the effective ingredient of microorganism composite fermentation technology to plant, the biological preparation obtained is had more easily absorb and utilize, the feature such as Be very effective, moreover, effectively can also realize the beneficial effect of antioxidation, scavenging free radicals, enhancing immunity, be a kind of can the natural biological preparation of enhancing human body immunity power.
Technical scheme of the present invention comprises a kind of preparation method of the biological preparation for enhancing human body immunity power, it is characterized in that, comprising:
Step 1: be mixed to get mixed vaccine according to the weight proportion of saccharomyces cerevisiae 10-20 part, Lactobacillus plantarum 20-30 part, bacillus bifidus 35-50 part, added in brown sugar water culture medium, under 32-35 DEG C of condition, the airtight pH of being cultured to is less than 3.60, then continue to cultivate 12-15 days, obtain compound bacteria;
Step 2: be mixed to get complex medium according to the weight proportion of Radix Puerariae 20-30 part, Fructus Hippophae 15-25 part, Semen Vitis viniferae 10-15 part, brown sugar 10-15 part, water 40-60 part;
Step 3: described compound bacteria is added in described complex medium, under 30-38 DEG C of condition, airtight cultivation 20-25 days, obtains composite fermentation thing;
Step 4: described composite fermentation thing is soaked, drip washing, concentrated, sterilizing, molding, obtain described biological preparation.
In one embodiment of the invention, wherein:
Described saccharomyces cerevisiae (Saccharomycescerevisiae) for deposit number be the strain of ACCC20065;
Described Lactobacillus plantarum (Lactobacillusplantarum) for deposit number be the strain of ACCC11118;
Described bacillus bifidus (Bifidobacterium) for deposit number be the strain of ACCC11054.
In a preferred embodiment of the invention, described preparation method also comprises the cultivation of strain, is specially:
Carry out shaken cultivation by saccharomyces cerevisiae strain access Rhizoma Solani tuber osi fluid medium, wherein, cultivation temperature is 28-32 DEG C, the revolution of shaken cultivation is 180-220rpm, duration of oscillation is 48-72 hour, takes out after culture medium muddiness, puts into 2-4 DEG C of Refrigerator store stand-by;
Lactobacillus plantarum strain, bifidobacterium species are accessed respectively in MRS fluid medium and carry out quiescent culture, wherein, cultivation temperature is 35-39 DEG C, and incubation time is 48-72 hour, takes out after culture medium muddiness, puts into 2-4 DEG C of Refrigerator store stand-by.
In one embodiment, about step 1, preferably, described mixed vaccine is added in brown sugar water culture medium according to the weight proportion of 1:80-120, and wherein, the component of described brown sugar water culture medium and weight proportion thereof are brown sugar 5-10 part, water 90-98 part.
In another embodiment, about step 2, preferably, described Radix Puerariae, Fructus Hippophae, Semen Vitis viniferae are pulverized by pulverizer, obtain 30-50 order granule.
In one embodiment, preferably, about step 3, described compound bacteria is added in described complex medium according to the weight proportion of 1:15-20.
In yet another embodiment, preferably, about step 4, wherein:
By adding in described composite fermentation thing, to add water to solid-liquid weight proportion be 1:1, soaks 1-2 days;
Then drip washing, and leacheate is concentrated into 20-30% under 40-50 DEG C of condition, obtain concentrated solution;
Further, sterilizing 10-30 minute under 60-70 DEG C of condition, obtains concentrated sterilized solution;
Described molding is the further course of processing, and wherein, described biological preparation can be solid formulation, can be also liquid formulation, as oral liquid;
Wherein, procedure of processing further about solid formulation is: according to concentrated sterilized solution 15-30 part, erythritol 15-30 part, lactose 30-60 part, the weight proportion of protective agent 3-5 part takes, first described erythritol and lactose are added in spraying dry one-step-granulating method successively, then start to spray into described concentrated sterilized solution, flow is 10-20ml/min, finally spray into the protective agent be dissolved in the water, wherein, the inlet temperature of described granulator is 60-80 DEG C, leaving air temp is 40-60 DEG C, discharging when temperature drops to 25-35 DEG C in day with fog to be painted, obtain described solid formulation,
Wherein, the procedure of processing further of described oral liquid is: take according to the weight proportion of concentrated sterilized solution 45-50 part, erythritol 45-50 part, protective agent 5-10 part; first dissolve adding appropriate hot water stirs in described erythritol and protective agent; to be cooled to after 25-35 DEG C; add described concentrated sterilized solution; stir to clarify, obtain described oral liquid.
Technical scheme of the present invention also comprises the described biological preparation that a kind of preparation method described above prepares, for enhancing human body immunity power.
The present invention adopts country to defend strain in " can be used for the strain list of food " of planning commission's bulletin, adopts conventional plant and fruit to be raw material, carries out composite fermentation and prepare a kind of natural biological preparation.The present invention combines the effective ingredient of the first kind in existing health product and Equations of The Second Kind, the active component of a large amount of oxidation resistance is rich in product, such as: flavonoid (4.73%), soaping agents (86.4mg/100g), aminoacid (4.01%), glutathion (886mg/100g), vitamin C (322mg/100g), vitamin E (908 μ g/100g), SOD (194000U/100g), lactate (5.04%) and various trace elements (ferrum: 503mg/kg; Selenium: 0.18mg/kg etc.) etc.
Technical scheme of the present invention has the function possessing enhancing immunity, transformed by the effective ingredient of microorganism composite fermentation technology to plant, make it have and more easily absorb, the features such as Be very effective, be a kind of can the natural biological preparation of enhancing immunity.
Detailed description of the invention
The invention provides a kind of preparation method of the biological preparation for enhancing human body immunity power, it is characterized in that, comprising:
Step 1: be mixed to get mixed vaccine according to the weight proportion of saccharomyces cerevisiae 10-20 part, Lactobacillus plantarum 20-30 part, bacillus bifidus 35-50 part, added in brown sugar water culture medium, under 32-35 DEG C of condition, the airtight pH of being cultured to is less than 3.60, then continue to cultivate 12-15 days, obtain compound bacteria;
Step 2: be mixed to get complex medium according to the weight proportion of Radix Puerariae 20-30 part, Fructus Hippophae 15-25 part, Semen Vitis viniferae 10-15 part, brown sugar 10-15 part, water 40-60 part;
Step 3: described compound bacteria is added in described complex medium, under 30-38 DEG C of condition, airtight cultivation 20-25 days, obtains composite fermentation thing;
Step 4: described composite fermentation thing is soaked, drip washing, concentrated, sterilizing, molding, obtain described biological preparation.
In one embodiment of the invention, wherein:
Described saccharomyces cerevisiae (Saccharomycescerevisiae) for deposit number be the strain of ACCC20065;
Described Lactobacillus plantarum (Lactobacillusplantarum) for deposit number be the strain of ACCC11118;
Described bacillus bifidus (Bifidobacterium) for deposit number be the strain of ACCC11054.
In a preferred embodiment of the invention, described preparation method also comprises the cultivation of strain, is specially:
Carry out shaken cultivation by saccharomyces cerevisiae strain access Rhizoma Solani tuber osi fluid medium, wherein, cultivation temperature is 28-32 DEG C, the revolution of shaken cultivation is 180-220rpm, duration of oscillation is 48-72 hour, takes out after culture medium muddiness, puts into 2-4 DEG C of Refrigerator store stand-by;
Lactobacillus plantarum strain, bifidobacterium species are accessed respectively in MRS fluid medium and carry out quiescent culture, wherein, cultivation temperature is 35-39 DEG C, and incubation time is 48-72 hour, takes out after culture medium muddiness, puts into 2-4 DEG C of Refrigerator store stand-by.
In one embodiment, about step 1, preferably, described mixed vaccine is added in brown sugar water culture medium according to the weight proportion of 1:80-120, and wherein, the component of described brown sugar water culture medium and weight proportion thereof are brown sugar 5-10 part, water 90-98 part.
In another embodiment, about step 2, preferably, described Radix Puerariae, Fructus Hippophae, Semen Vitis viniferae are pulverized by pulverizer, obtain 30-50 order granule.
In one embodiment, preferably, about step 3, described compound bacteria is added in described complex medium according to the weight proportion of 1:15-20.
In yet another embodiment, preferably, about step 4, wherein:
By adding in described composite fermentation thing, to add water to solid-liquid weight proportion be 1:1, soaks 1-2 days;
Then drip washing, and leacheate is concentrated into 20-30% under 40-50 DEG C of condition, obtain concentrated solution;
Further, sterilizing 10-30 minute under 60-70 DEG C of condition, obtains concentrated sterilized solution;
Described molding is the further course of processing, and wherein, described biological preparation can be solid formulation, can be also liquid formulation, as oral liquid;
Wherein, procedure of processing further about solid formulation is: according to concentrated sterilized solution 15-30 part, erythritol 15-30 part, lactose 30-60 part, the weight proportion of protective agent 3-5 part takes, first described erythritol and lactose are added in spraying dry one-step-granulating method successively, then start to spray into described concentrated sterilized solution, flow is 10-20ml/min, finally spray into the protective agent be dissolved in the water, wherein, the inlet temperature of described granulator is 60-80 DEG C, leaving air temp is 40-60 DEG C, discharging when temperature drops to 25-35 DEG C in day with fog to be painted, obtain described solid formulation,
Wherein, the procedure of processing further of described oral liquid is: take according to the weight proportion of concentrated sterilized solution 45-50 part, erythritol 45-50 part, protective agent 5-10 part; first dissolve adding appropriate hot water stirs in described erythritol and protective agent; to be cooled to after 25-35 DEG C; add described concentrated sterilized solution; stir to clarify, obtain described oral liquid.
Present invention also offers the described biological preparation that a kind of preparation method described above prepares, for enhancing human body immunity power.
Wherein, it should be noted that when not having specified otherwise, the content that the present invention relates to or proportioning refer to weight content or weight proportion.
According to technique scheme of the present invention, existing by following examples content of the present invention explained further and illustrate.
Embodiment 1
For a preparation method for the biological preparation of enhancing human body immunity power, comprising:
The first step: the cultivation of strain: by the saccharomyces cerevisiae strain (Saccharomycescerevisiae bought from Chinese agriculture Microbiological Culture Collection administrative center, ACCC20065) access in the conical flask of Rhizoma Solani tuber osi fluid medium, at 28 DEG C, 180-220rpm shaken cultivation 48 hours, takes out after culture medium muddiness; By Lactobacillus plantarum strain (Lactobacillusplantarum, ACCC11118), bifidobacterium species (Bifidobacterium, ACCC11054), access respectively in the conical flask of MRS fluid medium, cultivate 48 hours under 37 DEG C of conditions, take out after culture medium muddiness, then put into 4 DEG C of Refrigerator stores stand-by;
Second step: be mixed to get mixed vaccine according to the weight proportion of saccharomyces cerevisiae 15 parts, Lactobacillus plantarum 30 parts, bacillus bifidus 45 parts, added in brown sugar water culture medium according to the part by weight of 1:100, wherein, 5 parts, brown sugar, pure water 95 parts, after fermentation tank stirs, under 35 DEG C of conditions, the airtight pH of being cultured to is less than 3.60, then continue cultivation 15 days, obtain compound bacteria;
3rd step: filter out individual uniform Radix Puerariae, Fructus Hippophae, Semen Vitis viniferae, and be ground into 40 orders respectively by pulverizer, be mixed to get complex medium according to the weight proportion of Radix Puerariae 25 parts, Fructus Hippophae 20 parts, Semen Vitis viniferae 10 parts, 12 parts, brown sugar, 45 parts, water;
4th step: described compound bacteria is added in described complex medium by the part by weight of 1:20, after fermentation tank stirs, airtight cultivation 22 days under 32 DEG C of conditions, obtains composite fermentation thing;
5th step: add water in fermentation tank, make solid-to-liquid ratio reach 1:1, soak 1 day, then drip washing; Leacheate carries out being concentrated into 20% at 50 DEG C; After concentrated solution sterilizes 20 minutes at 60 DEG C, 4 DEG C of storages are stand-by;
6th step: the preparation of solid dosage: take according to the weight proportion of concentrated sterilized solution 20 parts, erythritol 20 parts, lactose 55 parts, protective agent 5 parts; first described erythritol and lactose are added in spraying dry one-step-granulating method successively; then start to spray into described concentrated sterilized solution; flow is 10ml/min; finally spray into the protective agent be dissolved in suitable quantity of water; wherein; the inlet temperature of described granulator is 60 DEG C; leaving air temp is 45 DEG C; discharging when temperature drops to 30 DEG C in day with fog to be painted, obtains described solid formulation.
Embodiment 2
For a preparation method for the biological preparation of enhancing human body immunity power, comprising:
The first step: the cultivation of strain: by the saccharomyces cerevisiae strain (Saccharomycescerevisiae bought from Chinese agriculture Microbiological Culture Collection administrative center, ACCC20065) access in the conical flask of Rhizoma Solani tuber osi fluid medium, at 28 DEG C, 180-220rpm shaken cultivation 48 hours, takes out after culture medium muddiness; By Lactobacillus plantarum strain (Lactobacillusplantarum, ACCC11118), bifidobacterium species (Bifidobacterium, ACCC11054), access respectively in the conical flask of MRS fluid medium, cultivate 48 hours under 37 DEG C of conditions, take out after culture medium muddiness, then put into 4 DEG C of Refrigerator stores stand-by;
Second step: be mixed to get mixed vaccine according to the weight proportion of saccharomyces cerevisiae 10 parts, Lactobacillus plantarum 30 parts, bacillus bifidus 50 parts, added in brown sugar water culture medium according to the part by weight of 1:100, wherein, 3 parts, brown sugar, pure water 97 parts, after fermentation tank stirs, under 33 DEG C of conditions, the airtight pH of being cultured to is less than 3.50, then continue cultivation 12 days, obtain compound bacteria;
3rd step: filter out individual uniform Radix Puerariae, Fructus Hippophae, Semen Vitis viniferae, and be ground into 40 orders respectively by pulverizer, be mixed to get complex medium according to the weight proportion of Radix Puerariae 30 parts, Fructus Hippophae 20 parts, Semen Vitis viniferae 12 parts, 10 parts, brown sugar, 40 parts, water;
4th step: described compound bacteria is added in described complex medium by the part by weight of 1:15, after fermentation tank stirs, airtight cultivation 25 days under 35 DEG C of conditions, obtains composite fermentation thing;
5th step: add water in fermentation tank, make solid-to-liquid ratio reach 1:1, soak 1 day, then drip washing; Leacheate carries out being concentrated into 20% at 45 DEG C; After concentrated solution sterilizes 10 minutes at 65 DEG C, 4 DEG C of storages are stand-by;
6th step: the preparation of oral liquid: take according to the weight proportion of concentrated sterilized solution 45 parts, erythritol 45 parts, protective agent 10 parts; first will add appropriate hot distilled water stirring and dissolving in described erythritol and protective agent; to be cooled to after 35 DEG C; add described concentrated sterilized solution; stir to clarify, obtain described oral liquid.
Detect embodiment
Animal divides into groups: select 90 healthy cleaning grade Kunming mouses, body weight 18-22g, after conventional adaptation feeds 2 days, be divided at random 3 groups (matched group, microbial source antioxidant group and composite antioxidant groups).
Experimental technique: test mice is fed basal diet, by table 1 gavage microbial source antioxidant and composite antioxidant, every day gavage once, gavage capacity is the distilled water of 0.2ml/10gbw, the capacity such as matched group filling, continuous gavage 30 days.Weigh a Mouse Weight weekly, adjustment gavage amount.
Table 1 mouse stomach dosage
The collection of sample and preparation:
1, the preparation of serum
Gavage is fasting 12h after 30 days, at 31d, takes a blood sample to pluck eyeball method, and low-temperature centrifugation after leaving standstill, gets supernatant sealing and be placed on preservation in cryogenic refrigerator, to be measured;
2, the collection of immune organ
31d, mice after blood sampling adopts cervical dislocation to put to death, rapid taking-up spleen and thymus, and the fat of rejecting around internal organs and connective tissue, by electronic balance weighing spleen and thymus weight in wet base, in order to Computation immunity shoot formation, wherein, select some at random, aseptically take out spleen for each group, in order to measure the conversion ratio of splenocyte.
Indexs measure and method:
1, Immune Organs Index
Thymus index (g/kg)=thymus weight in wet base (g)/Mouse Weight (kg),
Index and spleen index (g/kg)=spleen weight in wet base (g)/Mouse Weight (kg);
2, lymhocyte transformation rate
With mtt assay and tetramethyl azo azoles salt trace enzyme reaction colorimetric method for determining lymhocyte transformation rate;
3, immunoglobulin content
Immunoglobulin in Serum A (IgA), IgM (IgM), immunoglobulin G (IgG) all adopt enzyme linked immunosorbent assay (ELISA) to measure;
4, cytokine content
In serum, the content of interleukin-2 (IL-2), interleukin-6 (IL-6) all adopts enzyme linked immunosorbent assay (ELISA) to measure;
5, date processing
Data Processing in Experiment adopts the one factor analysis of variance of SPSS17.0 with analyzing, result represents with mean+SD.
Experimental result is in table 2 and table 3:
Table 2 mouse immune shoot formation
Project | Matched group | Microbial source antioxidant group | Composite antioxidant group |
Thymus Thymus | 3.644±0.704 | 3.909±0.807 | 4.232±0.618 |
Spleen Spleen | 3.270±0.585 | 3.413±0.709 | 3.154±0.525 |
The change of mouse spleen lymphocyte conversion ratio, immunoglobulin content and cytokine levels that table 3ConA induces
Project | Matched group | Microbial source antioxidant group | Composite antioxidant group |
Splenic vein hemodynamics rate | 0.331±0.028 | 0.374±0.023 | 0.367±0.021 |
IgA(μg/ml) | 22.46±9.12 | 38.01±2.09 | 33.18±2.73 |
IgM(μg/ml) | 6.26±4.52 | 9.80±1.55 | 9.00±3.31 |
IgG(μg/ml) | 25.63±0.52 | 24.66±2.28 | 23.03±3.38 |
IL-2(ng/L) | 23.24±7.09 | 37.04±11.00 | 42.94±7.22 |
IL-6(ng/L) | 92.83±24.17 | 140.35±39.29 | 143.79±45.45 |
By upper Biao Ke get: from Immune Organs Index, lymhocyte transformation rate, immunoglobulin content, cytokine content, antioxidant can improve the immune function of body, shows that the present invention has the effect of good enhancing immunity.
Further, adopt same above-mentioned requirement of experiment, the microbial origin antioxidant in oxidant group is replaced with the biological preparation prepared in embodiment 1 or 2, finally detect and find that its These parameters is close with oxidant group, be even better than oxidant group.
Be described in detail specific embodiments of the invention above, but it is just as example, the present invention is not restricted to specific embodiment described above.To those skilled in the art, any equivalent modifications that the present invention is carried out and substituting also all among category of the present invention.Therefore, equalization conversion done without departing from the spirit and scope of the invention and amendment, all should contain within the scope of the invention.
Claims (10)
1. for a preparation method for the biological preparation of enhancing human body immunity power, it is characterized in that, comprising:
Step 1: be mixed to get mixed vaccine according to the weight proportion of saccharomyces cerevisiae 10-20 part, Lactobacillus plantarum 20-30 part, bacillus bifidus 35-50 part, added in brown sugar water culture medium, under 32-35 DEG C of condition, the airtight pH of being cultured to is less than 3.6, then continues to cultivate 12-15 days, obtains compound bacteria;
Step 2: be mixed to get complex medium according to the weight proportion of Radix Puerariae 20-30 part, Fructus Hippophae 15-25 part, Semen Vitis viniferae 10-15 part, brown sugar 10-15 part, water 40-60 part;
Step 3: described compound bacteria is added in described complex medium, under 30-38 DEG C of condition, airtight cultivation 20-25 days, obtains composite fermentation thing;
Step 4: described composite fermentation thing is soaked, drip washing, concentrated, sterilizing, molding, obtain described biological preparation.
2. preparation method according to claim 1, is characterized in that, described saccharomyces cerevisiae (Saccharomycescerevisiae) for deposit number be the strain of ACCC20065; Described Lactobacillus plantarum (Lactobacillusplantarum) for deposit number be the strain of ACCC11118; Described bacillus bifidus (Bifidobacterium) for deposit number be the strain of ACCC11054.
3. preparation method according to claim 1, is characterized in that, also comprises the cultivation of strain, is specially:
Carry out shaken cultivation by saccharomyces cerevisiae strain access Rhizoma Solani tuber osi fluid medium, wherein, cultivation temperature is 28-32 DEG C, the revolution of shaken cultivation is 180-220rpm, duration of oscillation is 48-72 hour, takes out after culture medium muddiness, puts into 2-4 DEG C of Refrigerator store stand-by;
Lactobacillus plantarum strain, bifidobacterium species are accessed respectively in MRS fluid medium and carry out quiescent culture, wherein, cultivation temperature is 35-39 DEG C, and incubation time is 48-72 hour, takes out after culture medium muddiness, puts into 2-4 DEG C of Refrigerator store stand-by.
4. preparation method according to claim 1, it is characterized in that, about step 1, described mixed vaccine is added in brown sugar water culture medium according to the weight proportion of 1:80-120, wherein, the component of described brown sugar water culture medium and weight proportion thereof are brown sugar 5-10 part, water 90-98 part.
5. preparation method according to claim 1, is characterized in that, about step 2, described Radix Puerariae, Fructus Hippophae, Semen Vitis viniferae are pulverized by pulverizer, obtains 30-50 order granule.
6. preparation method according to claim 1, is characterized in that, about step 3, described compound bacteria is added in described complex medium according to the weight proportion of 1:15-20.
7. preparation method according to claim 1, is characterized in that, about step 4, wherein:
By adding in described composite fermentation thing, to add water to solid-liquid weight proportion be 1:1, soaks 1-2 days;
Then drip washing, and leacheate is concentrated into 20-30% under 40-50 DEG C of condition, obtain concentrated solution;
Further, sterilizing 10-30 minute under 60-70 DEG C of condition, obtains concentrated sterilized solution.
8. preparation method according to claim 1, it is characterized in that, described molding is the further course of processing, wherein, described biological preparation is solid formulation, procedure of processing further then about solid formulation is: according to concentrated sterilized solution 15-30 part, erythritol 15-30 part, lactose 30-60 part, the weight proportion of protective agent 3-5 part takes, first described erythritol and lactose are added in spraying dry one-step-granulating method successively, then start to spray into described concentrated sterilized solution, flow is 10-20ml/min, finally spray into the protective agent be dissolved in the water, wherein, the inlet temperature of described granulator is 60-80 DEG C, leaving air temp is 40-60 DEG C, discharging when temperature drops to 25-35 DEG C in day with fog to be painted, obtain described solid formulation.
9. preparation method according to claim 1; it is characterized in that; described biological preparation is liquid formulation; as oral liquid, then the procedure of processing further of described oral liquid is: take according to the weight proportion of concentrated sterilized solution 45-50 part, erythritol 45-50 part, protective agent 5-10 part, first dissolves adding appropriate hot water stirs in described erythritol and protective agent; to be cooled to after 25-35 DEG C; add described concentrated sterilized solution, stir to clarify, obtain described oral liquid.
10. the biological preparation prepared as the preparation method in claim 1-9 as described in any one.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201511005999.XA CN105497318A (en) | 2015-12-28 | 2015-12-28 | Biological agent used for enhancing immunity of organism and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201511005999.XA CN105497318A (en) | 2015-12-28 | 2015-12-28 | Biological agent used for enhancing immunity of organism and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105497318A true CN105497318A (en) | 2016-04-20 |
Family
ID=55705877
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201511005999.XA Pending CN105497318A (en) | 2015-12-28 | 2015-12-28 | Biological agent used for enhancing immunity of organism and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105497318A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106962724A (en) * | 2017-03-17 | 2017-07-21 | 赵玉良 | A kind of production technology of the probiotics solid beverage without chemical addition agent |
CN110314205A (en) * | 2019-05-30 | 2019-10-11 | 上海普乐拜格健康科技有限公司 | A kind of cultured fishes hepatic injury reparation natural biological preparation and preparation method thereof |
CN110464763A (en) * | 2019-08-30 | 2019-11-19 | 海南木辣达生物科技有限公司 | A kind of antipruritic antibacterial Moringa external application object and preparation method thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101690743A (en) * | 2009-09-30 | 2010-04-07 | 北京大北农动物保健科技有限责任公司 | Traditional Chinese medicine biological agent for improving immunity of livestock and preparation method thereof |
CN104623122A (en) * | 2015-01-12 | 2015-05-20 | 江瀚生物科技(上海)有限公司 | Biological preparation with anti-fatigue function and preparation method of biological preparation |
CN104971111A (en) * | 2014-04-14 | 2015-10-14 | 北京大北农动物保健科技有限责任公司 | Traditional Chinese medicine bio-preparation of improving immunity of livestock and poultry, preparation method thereof and feed therewith |
-
2015
- 2015-12-28 CN CN201511005999.XA patent/CN105497318A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101690743A (en) * | 2009-09-30 | 2010-04-07 | 北京大北农动物保健科技有限责任公司 | Traditional Chinese medicine biological agent for improving immunity of livestock and preparation method thereof |
CN104971111A (en) * | 2014-04-14 | 2015-10-14 | 北京大北农动物保健科技有限责任公司 | Traditional Chinese medicine bio-preparation of improving immunity of livestock and poultry, preparation method thereof and feed therewith |
CN104623122A (en) * | 2015-01-12 | 2015-05-20 | 江瀚生物科技(上海)有限公司 | Biological preparation with anti-fatigue function and preparation method of biological preparation |
Non-Patent Citations (1)
Title |
---|
金旭丹: "《神奇的元素》", 31 January 2007, 内蒙古人民出版社 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106962724A (en) * | 2017-03-17 | 2017-07-21 | 赵玉良 | A kind of production technology of the probiotics solid beverage without chemical addition agent |
CN110314205A (en) * | 2019-05-30 | 2019-10-11 | 上海普乐拜格健康科技有限公司 | A kind of cultured fishes hepatic injury reparation natural biological preparation and preparation method thereof |
CN110464763A (en) * | 2019-08-30 | 2019-11-19 | 海南木辣达生物科技有限公司 | A kind of antipruritic antibacterial Moringa external application object and preparation method thereof |
CN110464763B (en) * | 2019-08-30 | 2021-08-27 | 海南木辣达生物科技有限公司 | Itching-relieving and bacteriostatic moringa oleifera external application and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105087423B (en) | Novel Bei Laisi bacillus CJBV and the bactericidal composition containing it | |
CN111406856B (en) | Functional fermented beverage for dispelling effects of alcohol and protecting liver and preparation method thereof | |
CN104642771A (en) | Application of Chinese herbal medicine feed additive to livestock and poultry feed | |
CN104585489A (en) | An herbal dry-mixed feed and a preparation method thereof | |
CN104543384A (en) | Chinese herbal medicine feed additive | |
CN105166899A (en) | Fragrance flavored fruit and vegetable enzyme powder preparation method | |
CN104623122A (en) | Biological preparation with anti-fatigue function and preparation method of biological preparation | |
CN105497318A (en) | Biological agent used for enhancing immunity of organism and preparation method thereof | |
CN106190912A (en) | Photosynthetic bacteria microbial inoculum and preparation method and application | |
CN114191464B (en) | Traditional Chinese medicine microecological preparation for improving duck growth performance and application thereof | |
CN102204646A (en) | Feed for fattening adult pigs | |
CN105076830A (en) | Compound feed for channa maculate and preparation method of compound feed | |
CN106754427B (en) | Penicillium lanophorum Kong Junxin strain and domestication method thereof | |
CN103931665B (en) | A kind of mixing formula preparation preventing and treating brown planthopper | |
CN102851334B (en) | Fermentation medium and fermentation method of aflatoxin B1 | |
Ammar et al. | Nutritive value of ajuga iva as a pastoral plant for ruminants: plant phytochemicals and in vitro gas production and digestibility | |
CN104605149A (en) | Chinese herbal medicine mixed fermentation feed | |
TW200948371A (en) | Cultivation method and liquid culture medium for cultivation of mycelium and fruiting body of Cordyceps | |
CN103975957B (en) | A kind of mixing formula formulation preparation method preventing and treating brown planthopper | |
CN105535282A (en) | Biological agent for irritable infertility function repair and preparation method thereof | |
CN105558350A (en) | Feed containing Chinese herbal medicine compound crude polysaccharide and preparation method of feed | |
CN106190913A (en) | One strain Rhodopseudomonas palustris and store method thereof | |
CN103947684A (en) | Application of mixed formula preparation in prevention and treatment of brown planthopper | |
Alghamdi | Nutritional value and phytochemical constituents of some plantago spp. of ha‟ il region, Saudi Arabia | |
CN103550286B (en) | A kind of infectious bursal disease live-vaccine effervescent tablet immunological adjuvant |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160420 |